Skeletal muscle, the intricate network responsible for our voluntary movements and overall physical power, undergoes a gradual decline with advancing age, a process that can significantly impact an individual’s quality of life. This deterioration manifests as a noticeable reduction in muscular strength, an increase in scar tissue formation within muscle fibers, and an accumulation of adipose tissue, which can impair function. Furthermore, the population of fast-twitch muscle fibers, critical for explosive and rapid actions, tends to diminish, leading to decreased agility and responsiveness. Understanding the molecular mechanisms underlying this age-related muscle atrophy is paramount for developing therapeutic strategies to preserve function and independence in later life.
At the forefront of this vital research is a team led by Professor Ryuichi Tatsumi at Kyushu University’s Faculty of Agriculture, who have identified a promising molecular intervention capable of safeguarding and amplifying a crucial signaling pathway essential for skeletal muscle repair. The findings, detailed in a recent publication in the esteemed journal Scientific Reports on July 24, 2026, illuminate a novel approach to combatting age-induced muscle weakness.
The body’s innate capacity to mend damaged muscle tissue relies heavily on a signaling protein known as hepatocyte growth factor, or HGF. Under normal physiological conditions, HGF circulates in an inactive state, embedded within the extracellular matrix that encases muscle fibers. However, upon experiencing injury or significant mechanical stress, this protective dormancy is broken, triggering the release of HGF. Once liberated, HGF embarks on a critical mission, seeking out and binding to specific receptors, known as c-Met, located on the surface of satellite cells. These satellite cells are the specialized stem cells residing within muscle tissue, tasked with the ongoing maintenance and regeneration of muscle fibers. The binding of HGF to its c-Met receptor acts as a powerful signal, rousing these quiescent stem cells, prompting them to proliferate, differentiate, and ultimately contribute to the repair and rebuilding of compromised muscle structures.
However, the intricate machinery of muscle repair is not immune to the effects of aging. Previous investigations by Professor Tatsumi’s group have uncovered a significant age-related alteration in HGF’s functionality. They discovered that HGF can undergo a process of chemical modification called nitration, a reaction that attaches a nitro group to specific amino acid residues within the protein, namely at positions Y198 and Y250. Crucially, these nitrated sites are located within the very region of the HGF molecule that is responsible for its interaction with the c-Met receptor. This chemical modification effectively impairs HGF’s ability to dock with its intended target. The researchers aptly liken this functional loss to a key that has become corroded by rust, rendering it incapable of fitting into its lock. This compromised signaling cascade is hypothesized to be a key contributor to the progressive muscle wasting and diminished regenerative capacity observed in older adults.
Professor Tatsumi elaborated on this critical observation, stating, "HGF is not necessarily absent as we age; rather, its functional integrity can be compromised through chemical alteration after its synthesis. This led us to explore whether compounds possessing potent antioxidant capabilities might serve to protect HGF, either by preventing the nitration process itself or by mitigating the functional deficits that arise from it."
With this hypothesis in mind, the research team turned their attention to two compounds renowned for their robust antioxidant properties: glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS). Both of these molecules belong to the trisulfide class, characterized by a unique arrangement of three sulfur atoms linked in a chain. Trisulfides have emerged as subjects of considerable interest in pharmaceutical research due to their distinctive sulfur-based chemistry and their active participation in vital redox reactions within biological systems.
Initial laboratory experiments demonstrated that both GSSSG and LASSS were effective in reducing the extent of nitration at the Y198 and Y250 sites on the HGF protein. However, neither compound, when used at the tested concentrations, was able to fully restore HGF’s capacity to bind to its c-Met receptor. This suggested that simply neutralizing reactive species might not be the complete solution.
Undeterred, the researchers decided to systematically alter the experimental conditions, specifically by increasing the molar ratio of HGF to the trisulfide compounds. They shifted from an initial ratio of 1:4000 to a more concentrated ratio of 1:8000. This adjustment yielded a remarkable and unanticipated outcome.
When HGF was incubated with LASSS at this higher concentration, its affinity for the c-Met receptor surged dramatically, exceeding the binding capability of untreated HGF by more than twofold. Moreover, the protein exhibited a significantly enhanced resistance to the functional impairment caused by nitration, particularly at the Y198 site. This potent restorative effect was exclusively observed with LASSS; GSSSG, even at the increased ratio, did not elicit a comparable enhancement.
Professor Tatsumi expressed his astonishment at these findings, remarking, "This outcome surpassed our expectations. While we were aware of the diverse biological roles of trisulfides, we had not anticipated that the mere admixture of HGF with LASSS would precipitate such a striking improvement." He further hypothesized, "This suggests that LASSS may be acting through a mechanism that extends beyond simple neutralization of reactive molecules. It is plausible that LASSS directly interacts with HGF, inducing a subtle yet beneficial structural modification. This could result in the formation of a ‘Super HGF’ variant that exhibits both a stronger affinity for c-Met and increased resilience against nitrative damage." These observations point towards a potential direct structural modulation of HGF by LASSS, creating a more potent and resilient form of the growth factor.
To ascertain whether these salutary effects could translate to a living biological system, the research team extended their investigations to a mouse model. They employed a standard experimental paradigm for inducing muscle atrophy, involving tail suspension in mice. Mice that received LASSS treatment prior to the suspension period displayed significantly lower levels of protein nitration in their muscle tissue compared to their untreated counterparts. Consistent with the in vitro results, GSSSG administration did not confer any measurable protective benefits in this in vivo setting. These findings strongly indicate that the beneficial influence of LASSS on HGF is not confined to isolated protein experiments but can manifest within the complex environment of living tissue. Nevertheless, further rigorous studies, particularly involving aged animal models, are indispensable to definitively establish the safety and efficacy of LASSS for therapeutic applications in vivo.
This groundbreaking discovery holds substantial promise for the development of novel interventions aimed at preserving muscle repair capabilities across a spectrum of conditions. These include not only the natural aging process but also extended periods of immobility, such as those experienced during prolonged bed rest or recovery from severe illness. The researchers posit that the observed effects of LASSS on HGF may be conserved across different species, potentially extending to humans as well as companion animals like cats and dogs. In the long term, this therapeutic avenue could offer a vital strategy for enabling individuals to maintain their physical strength, retain their independence, enhance their overall quality of life, and contribute to a longer, healthier lifespan as they age.
About the Author
